Age‐specific 3‐year cumulative risk of cervical cancer and high‐grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting

التفاصيل البيبلوغرافية
العنوان: Age‐specific 3‐year cumulative risk of cervical cancer and high‐grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting
المؤلفون: Eric Luna, Jiaqiong Xu, Yimin Ge, Donna Armylagos, Jim Hsu, Mary R. Schwartz, Dina R. Mody, Paul A. Christensen, Haijun Zhou
المصدر: Cancer Cytopathology. 127:757-764
بيانات النشر: Wiley, 2019.
سنة النشر: 2019
مصطلحات موضوعية: Adult, Cancer Research, medicine.medical_specialty, Databases, Factual, Uterine Cervical Neoplasms, 030209 endocrinology & metabolism, Risk Assessment, Sensitivity and Specificity, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Cytology, Biopsy, medicine, Humans, Human papillomavirus, Papillomaviridae, Early Detection of Cancer, Retrospective Studies, Cervical cancer, Chi-Square Distribution, medicine.diagnostic_test, High grade dysplasia, business.industry, Obstetrics, Incidence, Biopsy, Needle, Papillomavirus Infections, Age Factors, Prognosis, medicine.disease, Immunohistochemistry, female genital diseases and pregnancy complications, Cumulative risk, Squamous intraepithelial lesion, Oncology, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Age stratification, Female, business, Papanicolaou Test
الوصف: BACKGROUND High-risk human papillomavirus (HPV)-Papanicolaou (Pap) cotesting is recommended for cervical cancer screening in women aged ≥30 years. The current study analyzed the effectiveness of cotesting on risk management in different age groups. METHODS A retrospective review of a 5-year cytology database identified 9434 women with HPV-Pap cotesting and follow-up cervical biopsy. The 3-year cumulative risk of developing high-grade cervical lesions (≥high-grade squamous intraepithelial lesion [HSIL]) was analyzed using age stratification. RESULTS The 3-year cumulative risk of developing ≥HSIL was found to be significantly different in women with baseline cotesting HPV-positive and Pap-positive results (HPV+/Pap+; defined as ≥atypical squamous cells of undetermined significance), HPV+ and Pap-negative results, and HPV-negative and Pap+ results at 19.2%, 7.9%, and 3.1%, respectively (P
تدمد: 1934-6638
1934-662X
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613b7fc014b63a73113eae05e8f28f17
https://doi.org/10.1002/cncy.22192
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....613b7fc014b63a73113eae05e8f28f17
قاعدة البيانات: OpenAIRE